NICE is urged to make drug companies supply all trial data
The drug regulator the National Institute for Health and Clinical Excellence should put more pressure on drug companies to produce all data in trials, MPs have said.
MPs on the parliamentary health select committee challenged the leaders of NICE to take action to tackle the issue of unpublished data from drug trials at an evidence session on Tuesday 4 December.
Michael Rawlins, NICE’s chairman, who will retire from the post next April, and its chief executive, Andrew Dillon, appeared before the Health Committee as part of its inquiry into the institute.
http://www.bmj.com/content/345/bmj.e8294?
No comments:
Post a Comment